The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inference of Population Structure Using Multilocus Genotype Data
Pritchard, J. K., Stephens, M., & Donnelly, P. (2000) · Genetics · doi:10.1093/genetics/155.2.945 · Cited by 33,908
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692
Genetics and Analysis of Quantitative Traits
(2002) · Journal of Animal Breeding and Genetics · doi:10.1046/j.1439-0388.2002.00356.x · Cited by 6,092
The Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355
Empirical threshold values for quantitative trait mapping.
Churchill, G. A., & Doerge, R. W. (1994) · Genetics · doi:10.1093/genetics/138.3.963 · Cited by 4,935
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmöller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3473 · Cited by 2,365
Rothman, K. J., Greenland, S., & Lash, T. L. (1998) · Cited by 2,096
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Expression of a multidrug-resistance gene in human tumors and tissues.
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.265 · Cited by 1,544
Association study designs for complex diseases
Cardon, L. R., & Bell, J. I. (2001) · Nature Reviews Genetics · doi:10.1038/35052543 · Cited by 1,395
Problems of reporting genetic associations with complex outcomes
Colhoun, H. M., McKeigue, P. M., & Smith, G. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12715-8 · Cited by 1,204
Use of Unlinked Genetic Markers to Detect Population Stratification in Association Studies
Pritchard, J. K., & Rosenberg, N. A. (1999) · The American Journal of Human Genetics · doi:10.1086/302449 · Cited by 1,198
On the allelic spectrum of human disease
Reich, D. E., & Lander, E. S. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02410-6 · Cited by 1,185
Identification of functionally variant MDR1 alleles among European Americans and African Americans
Kim, R. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.117412 · Cited by 1,009
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
Greiner, B., Eichelbaum, M., Fritz, P., Kreichgauer, H.-P., von Richter, O., Zundler, J., & Kroemer, H. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6663 · Cited by 917
Siddiqui, A., Kerb, R., Weale, M. E., Brinkmann, U., Smith, A., Goldstein, D. B., Wood, N. W., & Sisodiya, S. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021986 · Cited by 665
Fellay, J., Marzolini, C., Meaden, E. R., Back, D. J., Buclin, T., Chave, J.-P., Decosterd, L. A., Furrer, H., Opravil, M., Pantaleo, G., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07276-8 · Cited by 658
Tanabe, M., Ieiri, I., Nagata, N., Inoue, K., Ito, S., Kanamori, Y., Takahashi, M., Kurata, Y., Kigawa, J., Higuchi, S., et al. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29643-9 · Cited by 533
Control of confounding of genetic associations in stratified populations
Hoggart, C. J., Parra, E. J., Shriver, M. D., Bonilla, C., Kittles, R. A., Clayton, D. G., & McKeigue, P. M. (2003) · The American Journal of Human Genetics · doi:10.1086/375613 · Cited by 490
Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability
Wang, D., Johnson, A. D., Papp, A. C., Kroetz, D. L., & Sadée, W. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000178311.02878.83 · Cited by 490
Epidemiological methods for studying genes and environmental factors in complex diseases
Clayton, D., & McKeigue, P. M. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06418-2 · Cited by 470
Population genetic structure of variable drug response
Wilson, J. F., Weale, M. E., Smith, A. C., Gratrix, F., Fletcher, B., Thomas, M. G., Bradman, N., & Goldstein, D. B. (2001) · Nature Genetics · doi:10.1038/ng761 · Cited by 460
Haufroid, V., Mourad, M., Van Kerckhove, V., Wawrzyniak, J., De Meyer, M., Eddour, D. C., Malaise, J., Lison, D., Squifflet, J.-P., & Wallemacq, P. (2004) · Pharmacogenetics · doi:10.1097/00008571-200403000-00002 · Cited by 447
The barrier function of CYP3A4 and P-glycoprotein in the small bowel
Watkins, P. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00041-0 · Cited by 391
Effect of grapefruit juice on digoxin pharmacokinetics in humans
Becquemont, L., Verstuyft, C., Kerb, R., Brinkmann, U., Lebot, M., Jaillon, P., & Funck‐Brentano, C. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(01)17221-8 · Cited by 387
Hitzl, M., Drescher, S., van der Kuip, H., Schäffeler, E., Fischer, J., Schwab, M., Eichelbaum, M., & Fromm, M. F. (2001) · Pharmacogenetics · doi:10.1097/00008571-200106000-00003 · Cited by 374
Linkage disequilibrium mapping of complex disease: fantasy or reality?
Terwilliger, J. D., & Weiss, K. M. (1998) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(98)80135-3 · Cited by 352
Rosenberg, M. F., Callaghan, R., Ford, R. C., & Higgins, C. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10685 · Cited by 345
Sakaeda, T., Nakamura, T., Horinouchi, M., Kakumoto, M., Ohmoto, N., Sakai, T., Morita, Y., Tamura, T., Aoyama, N., Hirai, M., et al. (2001) · Pharmaceutical Research · doi:10.1023/a:1012244520615 · Cited by 322
Macphee, I. A. M., Fredericks, S., Tai, T., Syrris, P., Carter, N. D., Johnston, A., Goldberg, L., & Holt, D. W. (2002) · Transplantation · doi:10.1097/00007890-200212150-00002 · Cited by 315
Drug–drug interaction mediated by inhibition and induction of P-glycoprotein
Lin, J. H. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00171-0 · Cited by 309
Modulation of steady‐state kinetics of digoxin by haplotypes of the P‐glycoprotein MDR1 gene
Johne, A., Köpke, K., Gerloff, T., Mai, I., Rietbrock, S., Meisel, C., Hoffmeyer, S., Kerb, R., Fromm, M. F., Brinkmann, U., et al. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.129196 · Cited by 306
Kurata, Y., Ieiri, I., Kimura, M., Morita, T., Irie, S., Urae, A., Ohdo, S., Ohtani, H., Sawada, Y., Higuchi, S., et al. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.126177 · Cited by 269
Role of P-Glycoprotein in Drug Disposition
Tanigawara, Y. (2000) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200002000-00029 · Cited by 261
Sham, P. C., Cherny, S. S., Purcell, S., & Hewitt, J. K. (2000) · The American Journal of Human Genetics · doi:10.1086/302891 · Cited by 260
Nakamura, T., Sakaeda, T., Horinouchi, M., Tamura, T., Aoyama, N., Shirakawa, T., Matsuo, M., Kasuga, M., & Okumura, K. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.122055 · Cited by 260
Haas, D. W., Smeaton, L. M., Shafer, R. W., Robbins, G. K., Morse, G. D., Labbé, L., Wilkinson, G. R., Clifford, D. B., D’Aquila, R. T., De Gruttola, V., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/497610 · Cited by 257
Tsuchiya, N., Satoh, S., Tada, H., Li, Z., Ohyama, C., Sato, K., Suzuki, T., Habuchi, T., & Kato, T. (2004) · Transplantation · doi:10.1097/01.tp.0000137789.58694.b4 · Cited by 250
MDR1 gene polymorphisms and disposition of the P‐glycoprotein substrate fexofenadine
Drescher, S., Schaeffeler, E., Hitzl, M., Hofmann, U., Schwab, M., Brinkmann, U., Eichelbaum, M., & Fromm, M. F. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01591.x · Cited by 249
MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.
Illmer, T., Schuler, U. S., Thiede, C., Schwarz, U. I., Kim, R. B., Gotthard, S., Freund, D., Schäkel, U., Ehninger, G., & Schaich, M. A. (2002) · PubMed · Cited by 248
MDR1 Ala893 Polymorphism Is Associated with Inflammatory Bowel Disease
Brant, S. R., Panhuysen, C. I. M., Nicolae, D., Reddy, D. M., Bonen, D. K., Karaliukas, R., Zhang, L., Swanson, E., Datta, L. W., Moran, T., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/379927 · Cited by 236
Effect of grapefruit juice on digoxin pharmacokinetics in humans.
Becquemont, L., Verstuyft, C., Kerb, R., Brinkmann, U., Lebot, M., Jaillon, P., & Funck‐Brentano, C. (2001) · PubMed · Cited by 234
Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs
Sakaeda, T., Nakamura, T., & Okumura, K. (2003) · Pharmacogenomics · doi:10.1517/phgs.4.4.397.22747 · Cited by 231
Testing for Population Subdivision and Association in Four Case-Control Studies
Ardlie, K. G., Lunetta, K. L., & Seielstad, M. (2002) · The American Journal of Human Genetics · doi:10.1086/341719 · Cited by 222
An association study of 43 SNPs in 16 candidate genes with atorvastatin response
Thompson, J. F., Man, M., Johnson, K. J., Wood, L. S., Lira, M. E., Lloyd, D. B., Banerjee, P., Milos, P. M., Myrand, S. P., Paulauskis, J., et al. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500328 · Cited by 214
Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy
Tan, N. C. K., Heron, S. E., Scheffer, I. E., Pelekanos, J. T., McMahon, J. M., Vears, D. F., Mulley, J. C., & Berkovic, S. F. (2004) · Neurology · doi:10.1212/01.wnl.0000137051.33486.c7 · Cited by 211
Genetics of Complex Disease: Approaches, Problems, and Solutions
SCHORK, N. J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.4.12-tac-5 · Cited by 202
Roberts, R. L., Joyce, P. R., Mulder, R. T., Begg, E. J., & Kennedy, M. A. (2002) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500099 · Cited by 202
Potschka, H., Fedrowitz, M., & Löscher, W. (2001) · Neuroreport · doi:10.1097/00001756-200111160-00037 · Cited by 201
Siegmund, W., Ludwig, K., Giessmann, T., Dazert, P., Schroeder, E., Sperker, B., Warzok, R., Kroemer, H. K., & Cascorbi, I. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.127739 · Cited by 199
Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs
Baker, E. K., Johnstone, R. W., Zalcberg, J. R., & El-Osta, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208955 · Cited by 196
Sills, G. J., Mohanraj, R., Butler, E., McCrindle, S., Collier, L., Wilson, E. A., & Brodie, M. J. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.46304.x · Cited by 194
Jamroziak, K., Młynarski, W., Balcerczak, E., Mistygacz, M., Treliǹska, J., Mirowski, M., Bodalski, J., & Robak, T. (2004) · European Journal of Haematology · doi:10.1111/j.1600-0609.2004.00228.x · Cited by 194
HMG‐CoA reductase inhibitors and P‐glycoprotein modulation
Bogman, K., Peyer, A., Török, M., Küsters, E., & Drewe, J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703920 · Cited by 194
Goto, M., Masuda, S., Saito, H., Uemoto, S., Kiuchi, T., Tanaka, K., & Inui, K.-I. (2002) · Pharmacogenetics · doi:10.1097/00008571-200208000-00005 · Cited by 193
CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation
Anglicheau, D. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.01.009 · Cited by 193
Yamauchi, A., Ieiri, I., Kataoka, Y., Tanabe, M., Nishizaki, T., Oishi, R., Higuchi, S., Otsubo, K., & Sugimachi, K. (2002) · Transplantation · doi:10.1097/00007890-200208270-00024 · Cited by 184
An utter refutation of the ‘Fundamental Theorem of the HapMap’
Terwilliger, J. D., & Hiekkalinna, T. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201583 · Cited by 174
Nakayama, M., Wada, M., Harada, T., Nagayama, J., Kusaba, H., Ohshima, K., Kozuru, M., Komatsu, H., Ueda, R., & Kuwano, M. (1998) · Blood · doi:10.1182/blood.v92.11.4296 · Cited by 172
Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy
Zimprich, F., Sunder-Plassmann, R., Stogmann, E., Gleiss, A., Dal-Bianco, A., Zimprich, A., Plumer, S., Baumgartner, C., & Mannhalter, C. (2004) · Neurology · doi:10.1212/01.wnl.0000141021.42763.f6 · Cited by 171
Digoxin pharmacokinetics and MDR1 genetic polymorphisms
Verstuyft, C., Schwab, M., Schaeffeler, E., Kerb, R., Brinkmann, U., Jaillon, P., Funck-Brentano, C., & Becquemont, L. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0567-5 · Cited by 166
Kimchi‐Sarfaty, C., Gribar, J. J., & Gottesman, M. M. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.1 · Cited by 156
Gerloff, T., Schaefer, M., Johne, A., Oselin, K., Meisel, C., Cascorbi, I., & Roots, I. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01691.x · Cited by 151
Zheng, H., Zeevi, A., Schuetz, E. G., Lamba, J. K., McCurry, K. R., Griffith, B. P., Webber, S., Ristich, J., Dauber, J. H., Iacono, A. T., et al. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003262108 · Cited by 149
Carbamazepine is not a substrate for P‐glycoprotein
Owen, A., Pirmohamed, M., Tettey, J. N. A., Morgan, P., Chadwick, D. W., & Park, B. K. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01359.x · Cited by 146
Self-citationAsano, T., Takahashi, K. A., Fujioka, M., Inoue, S., Okamoto, M., Sugioka, N., Nishino, H., Tanaka, T., Hirota, Y., & Kubo, T. (2003) · Pharmacogenetics · doi:10.1097/00008571-200311000-00003 · Cited by 143
Sai, K., Kaniwa, N., Itoda, M., Saito, Y., Hasegawa, R., Komamura, K., Ueno, K., Kamakura, S., Kitakaze, M., Shirao, K., et al. (2003) · Pharmacogenetics · doi:10.1097/00008571-200312000-00005 · Cited by 143
Hitzl, M., Schaeffeler, E., Hocher, B., Slowinski, T., Halle, H., Eichelbaum, M. F., Kaufmann, P., Fritz, P., Fromm, M. F., & Schwab, M. G. (2004) · Pharmacogenetics · doi:10.1097/00008571-200405000-00006 · Cited by 137
Moriya, Y., Nakamura, T., Horinouchi, M., et al. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.1356 · Cited by 127
Logistic regression protects against population structure in genetic association studiesPreprint
Setakis, E., Stirnadel-Farrant, H. A., & Balding, D. J. (2005) · Genome Research · doi:10.1101/gr.4346306 · Cited by 123
Human MDR1 polymorphism: G2677T/A and C3435T have no effect on MDR1 transport activities
Morita, N., Yasumori, T., & Nakayama, K. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00178-3 · Cited by 122
Kajinami, K., Brousseau, M. E., Ordovás, J. M., & Schaefer, E. J. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.01.014 · Cited by 122
Complex Haplotypic Effects of the ABCB1 Gene on Epilepsy Treatment Response
Hung, C., Tai, J. J., Lin, C., Lee, M., & Liou, H. (2005) · Pharmacogenomics · doi:10.1517/14622416.6.4.411 · Cited by 116
Tada, H., Tsuchiya, N., Satoh, S., Kagaya, H., Li, Z., Sato, K., Miura, M., Suzuki, T., Kato, T., & Habuchi, T. (2005) · Transplantation Proceedings · doi:10.1016/j.transproceed.2005.02.073 · Cited by 110
Zheng, H., Webber, S., Zeevi, A., Schuetz, E. G., Zhang, J., Lamba, J. K., Bowman, P., & Burckart, G. J. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00426-3 · Cited by 108
Zhao, Z., Sheps, J. A., Ling, V. W. T., Fang, L. L., & Baillie, D. L. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.09.052 · Cited by 97
Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer
Zhou, Q. S., Sparreboom, A., Tan, E.-H., Cheung, Y., Lee, A., Poon, D. Y. H., Lee, E. J. D., & Chowbay, B. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02330.x · Cited by 94
Nasi, M., Borghi, V., Pinti, M., Bellodi, C., Lugli, E., Maffei, S., Troiano, L., Richeldi, L., Mussini, C., Esposito, R., et al. (2003) · AIDS · doi:10.1097/00002030-200307250-00016 · Cited by 94
Tang, C., Lin, J. H., & Lu, A. Y. H. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.003236 · Cited by 89
Maines, L. W., Antonetti, D. A., Wolpert, E. B., & Smith, C. D. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.028 · Cited by 88
Number of SNPS Loci Needed to Detect Population Structure
Turakulov, R. I., & Easteal, S. (2003) · Human Heredity · doi:10.1159/000071808 · Cited by 87
Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues
Jetté, L., Beaulieu, É., Leclerc, J., & Béliveau, R. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.5.f756 · Cited by 83
Meissner, K., Jedlitschky, G., zu Schwabedissen, H. E. M., et al. (2004) · Pharmacogenetics · doi:10.1097/00008571-200406000-00007 · Cited by 79
Guidelines for association studies in Human Molecular Genetics
Freimer, N. B., & Sabatti, C. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi251 · Cited by 78
Knutsen, T., Mickley, L. A., Ried, T., Green, E. D., du Manoir, S., Schröck, E., Macville, M. V. E., Ning, Y., Robey, R. W., Polymeropoulos, M. H., et al. (1998) · Genes Chromosomes and Cancer · Cited by 77
Single nucleotide polymorphisms in the multidrug resistance 1 gene in Korean epileptics
Kim, Y. O., Kim, M. K., Woo, Y. J., Lee, M. C., Kim, J. H., Park, K. W., Kim, E. Y., Roh, Y., & Kim, C. J. (2006) · Seizure · doi:10.1016/j.seizure.2005.11.001 · Cited by 76
Colombo, S. F., Soranzo, N., Rotger, M., Sprenger, R., Bleiber, G., Furrer, H., Buclin, T., Goldstein, D. B., Decosterd, L. A., & Telenti, A. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000172241.42546.d3 · Cited by 72
Owen, A., Goldring, C. E., Morgan, P., et al. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02229.x · Cited by 72
Leschziner, G. D., Zabaneh, D., Pirmohamed, M., Owen, A., Rogers, J., Coffey, A. J., Balding, D. J., Bentley, D., & Johnson, M. R. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000197467.21964.67 · Cited by 71
Self-citationRomiti, N., Tramonti, G., Donati, A., & Chieli, E. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.06.015 · Cited by 68
Kusaba, H., Nakayama, M., Harada, T., Nomoto, M., Kohno, K., Kuwano, M., & Wada, M. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00469.x · Cited by 67
Kuzuya, T., Kobayashi, T., 森山, 奈., Nagasaka, T., Yokoyama, I., Uchida, K., Nakao, A., & Nabeshima, T. (2003) · Transplantation · doi:10.1097/01.tp.0000084873.20157.67 · Cited by 55
Bercovich, D., Friedlander, Y., Korem, S., Houminer, A., Hoffman, A., Kleinberg, L., Shochat, C., Leitersdorf, E., & Meiner, V. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.05.025 · Cited by 52
Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania
Luca, V. D., Mundo, E., Trakalo, J., Wong, G. W. H., & Kennedy, J. L. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500196 · Cited by 46
Detecting multiple associations in genome-wide studies
Dudbridge, F., Gusnanto, A., & Koeleman, B. P. C. (2006) · Human Genomics · doi:10.1186/1479-7364-2-5-310 · Cited by 44
Kaya, P., Gündüz, U., Arpacı, F., Ural, A. U., & Güran, Ş. (2005) · American Journal of Hematology · doi:10.1002/ajh.20427 · Cited by 27
Uwai, Y., Masuda, S., Goto, M., et al. (2003) · Journal of Human Genetics · doi:10.1007/s10038-003-0105-4 · Cited by 26
Sequential Analysis of Tacrolimus Dosing in Adult Lung Transplant Patients With ABCB1 Haplotypes
Zheng, H., Schuetz, E. G., Zeevi, A., Zhang, J., McCurry, K. R., Webber, S. A., Iacono, A. T., Lamba, J. K., & Burckart, G. J. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005274507 · Cited by 14
Nishioka, C., Sakaeda, T., Nakamura, T., et al. (2004) · PubMed · doi:10.24546/00422052 · Cited by 14
(2000) · doi:10.1002/1098-2272(200101)20:1<4::aid-gepi2>3.0.co;2-t
Cited by
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
Simon, T., Verstuyft, C., Mary-Krause, M., Quteineh, L., Drouet, E., Méneveau, N., Steg, P. G., Ferrières, J., Danchin, N., & Becquemont, L. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808227 · Cited by 1,728
ABC Multidrug Transporters: Structure, Function and Role in Chemoresistance
Sharom, F. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.1.105 · Cited by 973
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
Zhou, S.-F. (2008) · Xenobiotica · doi:10.1080/00498250701867889 · Cited by 599
Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers
Tang, F., Hartz, A. M. S., & Bauer, B. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00301 · Cited by 482
Very important pharmacogene summary
Hodges, L. M., Markova, S. M., Chinn, L. W., Gow, J. M., Kroetz, D. L., Klein, T. E., & Altman, R. B. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283385a1c · Cited by 436
Metadata
- Authors
- Leschziner, G. D., Andrew, T., Pirmohamed, M., & Johnson, M. R.
- Venue
- The Pharmacogenomics Journal
- Published
- 2006-09-12
- Volume
- 7
- Issue
- 3
- Pages
- 154-179
- ISSN
- 1470-269X (ISSN-L)
- 1473-1150
- OpenAlex
- W2000357710
- Cited by
- 300
- References
- 103
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.